Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt issuances Wages, Salaries and Other

Neuroone Medical Technologies (NMTC) Shares Issued (2021 - 2026)

Neuroone Medical Technologies filings provide 6 years of Shares Issued readings, the most recent being $496025.0 for Q1 2026.

On a quarterly basis, Shares Issued changed N/A to $496025.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $326113.0, a N/A change, with the full-year FY2025 number at $69750.0, down 91.66% from a year prior.
Shares Issued hit $496025.0 in Q1 2026 for Neuroone Medical Technologies, up from $174375.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $9.2 million in Q2 2025 to a low of -$9.5 million in Q3 2025.
Median Shares Issued over the past 4 years was $886377.5 (2023), compared with a mean of $330377.3.
The widest YoY moves for Shares Issued: up 446.5% in 2025, down 127.4% in 2025.
Neuroone Medical Technologies' Shares Issued stood at $1.3 million in 2023, then crashed by 434.09% to -$4.2 million in 2024, then soared by 104.15% to $174375.0 in 2025, then soared by 184.46% to $496025.0 in 2026.
The last three reported values for Shares Issued were $496025.0 (Q1 2026), $174375.0 (Q4 2025), and -$9.5 million (Q3 2025) per Business Quant data.